Systematic review evaluates the role of CGMS on glycaemic control and outcomes in gestational diabetes, suggesting benefits for maternal and fetal health.
Key Points
CGMS use is linked to improved glycaemic control during pregnancy, helping to prevent hypoglycaemia and hyperglycaemia.
The review analyzed data from 12 studies on CGMS performance in gestational diabetes management.
Significant benefits include lower rates of preeclampsia and enhanced neonatal outcomes, showing promise for maternal health.
Heterogeneity in existing data indicates a need for larger studies to confirm the benefits of CGMS in gestational diabetes.